JPMorgan Chase & Co (JPM)

340.00
-12.04 (-3.42%)
NYSE · Last Trade: Sep 22nd, 6:49 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Tuesday's session: top gainers and losers in the dow jones indexchartmill.com
Via Chartmill · September 22, 2026
The Nasdaq Set a Record and the Dow Lost 270 Points on the Same Morningfool.com
The Nasdaq set a record on Tuesday morning while the Dow dropped 270 points. Neither move had much news behind it.
Via The Motley Fool · September 22, 2026
Charles Schwab, JPMorgan Chase Slide On Vanguard-Backed AI Threatinvestors.com
Schwab's biggest threat just got acquired by Vanguard.
Via Investor's Business Daily · September 22, 2026
Stock Market Midday, Sept. 22: Means Markets Muted Despite Tech Gains as Geopolitics Dominatesfool.com
Investors watch for developments in the Middle East as rally slows on further oil uncertainty, today, Sept. 22, 2026.
Via The Motley Fool · September 22, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · September 22, 2026
Analog Devices Sees Double-Digit Growth Into 2027 on Data Center, Industrial Demandmarketbeat.com
Analog Devices (NASDAQ:ADI) Chief Financial Officer Rich Puccio said the company expects demand strength across its portfolio to support double-digit growth into fiscal 2027, citing broad-based recovery in industrial markets alongside continued momentum in data centers, aerospace and defense, and au
Via MarketBeat · September 22, 2026
Should You Buy Moderna Stock? Why Many Wall Street Analysts Say "No."fool.com
Following last month's super rally, a growing number of analysts are now calling for caution.
Via The Motley Fool · September 22, 2026
Jamie Dimon Says AI Spending Could Hit $1 Trillion Next Yeartalkmarkets.com
JPMorgan Chase CEO Jamie Dimon sees no slowdown in the AI spending boom. Speaking to CNBC-TV18 at the bank's India conference, he said investment across th
Via Talk Markets · September 22, 2026
Teva CEO Details Biopharma Pivot, $700M Savings Plan and Growth Pipelinemarketbeat.com
Teva Pharmaceutical Industries (NYSE:TEVA) Chief Executive Officer Richard Francis said the company has shifted from being viewed primarily as a generics manufacturer toward a biopharmaceutical company with a growing innovative medicines portfolio, while maintaining and expanding its generics operat
Via MarketBeat · September 22, 2026
Jamie Dimon Just Said 8 Words Warning the American Dream Is "Slipping Out of Reach for Too Many People." Here's the Retirement Wave Behind His Warning and What It Means for the Economy JPMorgan Serves.fool.com
Jamie Dimon is warning Wall Street that Main Street may not be ready for what comes next.
Via The Motley Fool · September 21, 2026
Uranium Stocks Are Rallying. Why NXE Got Initiated At Overweight.investors.com
In a boost for the sector, JPMorgan highlighted uranium supply deficits.
Via Investor's Business Daily · September 21, 2026
Meta’s Muse Agent Has Wall Street Divided on Its AI Potentialmarketbeat.com
Meta's new Muse AI agent boosted shares and app downloads, but analysts at J.P. Morgan, Mizuho, and Oppenheimer disagree on its adoption and monetization potential.
Via MarketBeat · September 21, 2026
The Ultimate Dividend Growth stock to Buy With $1,000 Right Now.fool.com
Coca-Cola isn't cheap, but it is executing well in a difficult market and has an incredible dividend history.
Via The Motley Fool · September 20, 2026
Prediction: The Best-Performing Big Bank Stock of the Next 2 Years Is Not JPMorgan Chasefool.com
These fast-growing bank stocks offer incredible opportunities for investors.
Via The Motley Fool · September 20, 2026
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Downfool.com
The unlocking of SpaceX shares is reshaping the communications sector.
Via The Motley Fool · September 20, 2026
The Bond Market Is Rattled, and History Says That Could Be a Warning Signal to Investorsfool.com
Bond yields rose ahead of the Fed rate hike, and investors should be worried about Wall Street and Main Street.
Via The Motley Fool · September 20, 2026
The Unexpected Rival Threatening to Shake Up CoreWeave's Marketfool.com
The timing is right for this Bitcoin miner turned AI cloud provider.
Via The Motley Fool · September 19, 2026
The S&P 500 Is 3% Below Its Record. Should You Buy Vanguard's Index Fund Now, or Wait for a Correction?fool.com
Should you take the market's small discount now, or hold out for a bigger one?
Via The Motley Fool · September 18, 2026
Anthropic Is Expected to Go Public in October. The Brokerages Get Paid Either Way.fool.com
The two lead advisors generated record revenue in Q2, fueled by the SpaceX IPO. Will the Anthropic IPO have a similar impact?
Via The Motley Fool · September 18, 2026
Prediction: The Invesco QQQ Trust Beats the S&P 500 Again Over the Next 5 Yearsfool.com
Both funds are built on the same market leaders. The difference is how much -- and what gets left out.
Via The Motley Fool · September 17, 2026
JEPI and JEPQ Yield Way More Than SCHD, but SCHD Could Produce More Passive Income Over the Long Term. Here's Why.fool.com
Long-term holders of the Schwab U.S. Dividend Equity ETF have seen their yield on cost gradually rise.
Via The Motley Fool · September 17, 2026
Bank ETF FTXO Delivered a 20% Return Over the Last Year. Here's Why I'd Choose IYF Instead.fool.com
FTXO targets banks with concentrated holdings and higher volatility, while IYF offers broader sector exposure at lower cost.
Via The Motley Fool · September 17, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · September 16, 2026
5 Buy-and-Hold Stocks Built to Weather a Volatile Marketmarketbeat.com
Ahead of Q4 2026, analysts favor Western Digital, NVIDIA, Vertiv, Eli Lilly, and JPMorgan Chase as steady, best-in-class stocks offering growth with less volatility for buy-and-hold investors.
Via MarketBeat · September 16, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · September 16, 2026